FONKO-GEMCITABINE LYOPHILIZED POWDER FOR SOLUTION FOR INFUSION 200MG/VIAL
Product details
Registration number: SIN16771P
Classification: Prescription Only
Active ingredients: Gemcitabine Hydrochloride eqv Gemcitabine
Strength: 200mg/vial
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: INTRAVENOUS
Registrant: GLORIOUS DEXA SINGAPORE PTE. LTD.
ATC code: L01BC05
HSA approval date: 3 May 2023
Manufacturer(s): PT Fonko International Pharmaceuticals
Manufacturing country/countries: INDONESIA REP OF
What are the HSA registration number and classification for FONKO-GEMCITABINE LYOPHILIZED POWDER FOR SOLUTION FOR INFUSION 200MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16771P
Classification: Prescription Only
What active ingredients and strength are recorded for FONKO-GEMCITABINE LYOPHILIZED POWDER FOR SOLUTION FOR INFUSION 200MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Gemcitabine Hydrochloride eqv Gemcitabine
Strength: 200mg/vial
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for FONKO-GEMCITABINE LYOPHILIZED POWDER FOR SOLUTION FOR INFUSION 200MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: INTRAVENOUS
Who is the recorded registrant for FONKO-GEMCITABINE LYOPHILIZED POWDER FOR SOLUTION FOR INFUSION 200MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Registrant: GLORIOUS DEXA SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for FONKO-GEMCITABINE LYOPHILIZED POWDER FOR SOLUTION FOR INFUSION 200MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): PT Fonko International Pharmaceuticals
Manufacturing country/countries: INDONESIA REP OF
Where can I look up FONKO-GEMCITABINE LYOPHILIZED POWDER FOR SOLUTION FOR INFUSION 200MG/VIAL in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16771P or the exact product name FONKO-GEMCITABINE LYOPHILIZED POWDER FOR SOLUTION FOR INFUSION 200MG/VIAL. The general register link does not preselect this product.
What are the source dates for this FONKO-GEMCITABINE LYOPHILIZED POWDER FOR SOLUTION FOR INFUSION 200MG/VIAL record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this FONKO-GEMCITABINE LYOPHILIZED POWDER FOR SOLUTION FOR INFUSION 200MG/VIAL record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16771P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)